18-Aug-2026 Greener neighborhoods linked to lower type 2 diabetes risk Higher Education Press Type 2 diabetes (T2D) develops through the long-term interplay of genetic predisposition, lifestyle, and environmental exposures. Residential greenness is increasingly studied as a measurable environmental exposure that may be related to diabetes risk. However, prospective evidence from Chinese populations remains limited, and whether genetic susceptibility modifies the greenness–T2D association, particularly in terms of absolute risk reduction, has remained unclear. Journal Life Metabolism
18-Aug-2026 Age shapes the cardiovascular impact of ABC risk factors in diabetes: Insights from the 4C Cohort Higher Education Press Diabetes is a highly prevalent chronic condition and a major contributor to the global burden of disease, posing substantial challenges to health systems. Cardiovascular disease (CVD) remains its leading complication, and people with diabetes face a two- to four-fold higher risk of cardiovascular morbidity and mortality than the general population. Control of glycated hemoglobin (HbA1c), blood pressure, and low-density lipoprotein cholesterol (LDL-C), collectively referred to as ABC risk factors, is a cornerstone of cardiovascular prevention in diabetes. Journal Life Metabolism
18-Aug-2026 A functionally integrated cross-tissue alternative splicing program during short-term calorie restriction Higher Education Press Aging is a major risk factor for chronic diseases, and calorie restriction (CR) is a robust non-pharmacological intervention that can extend health span in multiple species. Alternative splicing (AS) generates multiple RNA isoforms from a single pre-mRNA and becomes dysregulated with age; intriguingly, prior work suggests that CR can attenuate age-associated splicing noise. What has remained unclear is whether AS responses to CR are coordinated across tissues and whether they scale with the level of restriction. Journal Life Metabolism
18-Aug-2026 Integrating heart imaging and proteomics identifies drug targets for cardiovascular diseases Higher Education Press As an emerging branch of clinical medicine, microbiota medicine has attracted worldwide attention from clinicians, medical educators, patient communities, and industry. However, this developing field still lacks consensus on its fundamental principles as well as guidelines for clinical and educational practice. An expert panel was convened by the journal Microbiota Medicine Research at the 2025 CHINAGUT Conference to develop the principles and practice guidelines of microbiota medicine.
18-Aug-2026 Molecular characterization of HIV-1 subtypes and primary drug resistance mutations in Bangladesh: Insights from 2019 data Bentham Science Publishers Acquired Immunodeficiency Syndrome (AIDS) caused by Human Immunodeficiency Virus (HIV) has been a significant public health concern for over four decades. Globally, more than 75 million individuals have been infected, with an estimated 32.7 million deaths attributed to AIDS-related complications. Even though there are continuous advancements in treatment and prevention, in 2019, about 1.7 million new infections were reported, which represents a 23% decline in new diagnoses compared to 2010, The high frequency of the D121 polymorphism, though not directly linked to treatment failure, reflects underlying genetic variability that may influence future resistance pathways Journal The Open AIDS Journal
18-Aug-2026 Proline-producing enzyme P5CS identified as a key driver of metabolic fatty liver disease Higher Education Press Metabolic dysfunction-associated steatotic liver disease (MASLD), a spectrum of liver conditions ranging from simple steatosis to steatohepatitis (MASH), fibrosis, and cirrhosis, represents a global health epidemic with no approved pharmacotherapies. Journal Life Metabolism
17-Aug-2026 Ethics & Human Research, July-August 2026 The Hastings Center Ethics & Human Research, July-August 2026 issue, includes an essay on organ-on-a-chip technology and articles on the All of Us research program and on consent and decisional capacity. Journal Ethics & Human Research
17-Aug-2026 Study finds advanced genetic testing opens new treatment options for nearly one in three cancer patients London Health Sciences Centre Research Institute A London Health Sciences Centre Research Institute study found that expanded genetic testing identified new treatment options for 28 per cent of cancer patients by uncovering tumour mutations often missed by standard testing. The approach could support more personalized, safer and potentially more cost-effective cancer care. Journal Journal of Molecular Diagnostics
16-Aug-2026 Investigation of heavy metal risks in liquid foundation products Journal of Dermatologic Science and Cosmetic Technology This study systematically evaluates heavy metal contamination in liquid foundation products using inductively coupled plasma mass spectrometry, with particular attention to thallium, a highly toxic neurotoxic metal. Most detected substances remained within the limits specified by China’s Safety and Technical Standards for Cosmetics (2015). However, thallium concentrations in two product batches exceeded the reference limits. Further source analysis showed a notably high thallium detection rate in samples containing zinc oxide, suggesting contamination during zinc oxide production. The findings highlight the need for stricter raw material control, improved thallium removal technologies, independent testing, and more refined safety standards for vulnerable populations.
